Liver Medicine Trials
-
05/07/2019
B-SMaRTStudy
Beta-blocker Stratification using quantitative MRI techniques to assess portal pressure and Response to Treatment in patients with portal hypertension.
View Trial -
28/02/2020
Protocol for a prospective cohort study to develop and validate AScites Quality of Life questionnaire (ASQoL)
View Trial -
31/12/2012
Review of renal dysfunction in recipients of orthotopic liver allografts in the UK
View Trial -
NIHR BioResource – Research Tissue Bank
View Trial -
31/10/2022
LITMUS
The European NAFLD Registry – LITMUS (Liver Investigation: Testing Marker Utility in Steatohepatitis)
View Trial -
31/12/2021
RESOLVE IT
A Multicenter Randomized Double-Blind Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Elafibranor in Patients with Nonalcoholic Steatohepatitis (NASH) and fibrosis
View Trial -
30/06/2024
The REGENERATE Study
A Phase 3 Double-Blind Randomized Long-Term Placebo-Controlled Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects with Nonalcoholic Steatohepatitis
View Trial -
31/07/2015
Chart Review To Characterise Resource Utilisation Associated With Managing Non-infant Lysosomal Acid Lipase Deficiency
View Trial -
01/05/2019
A multi-centre double-blind parallel-group randomised placebo controlled phase II a study to investigate safety tolerability pharmacodynamics and pharmacokinetics of different doses of orally administered BI 1467335 during a 12-week treatment period compared to placebo in patients with clinical evidence of NASH.
View Trial -
30/08/2020
AURORA
AURORA: A Phase 3 Multicenter Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Cenicriviroc for the Treatment of Liver Fibrosis in Adult Subjects with Nonalcoholic Steatohepatitis
View Trial